CoreAge Rx
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
- Sema
- $99/mo
- Tirz
- $149/mo
- Coverage
- All 50 states
Try Ageless sits at No. 320 in our ranking with a Brief Score of 58. Here are the GLP-1 desks we'd weigh against it — ranked on the same six-factor Brief Score, top down.
Prefer a straight head-to-head? CoreAge Rx vs Try Ageless.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
VirtualCare2Go is a US telehealth provider offering compounded GLP-1 weight-loss medication with same-day visits and national shipping.
A nationwide desk with an oral option — full-formulary, but priced at the premium end.
Apex MD is a US virtual telemedicine platform licensed in all 50 states that prescribes compounded GLP-1 medications for weight loss.
A newer (2024) compounding desk whose real hook is form: it runs an oral/sublingual line alongside the usual injections, on both molecules, with no membership tacked on.
FDA warning letter, September 2025 — issued to directmeds.com, Inc. dba DirectMeds. See the FDA's warning letter database.
RedBox Rx is a US telehealth pharmacy (parent company Hy-Vee) offering compounded GLP-1 weight management with flat, dose-independent pricing.
A six-shelf prescription telehealth catalog whose GLP-1 price genuinely holds flat as you titrate — but whose every advertised figure is a twelve-month prepay rate, with the month-to-month price published nowhere.
Tell Her Doc is a women-focused, self-pay telehealth program for compounded GLP-1 weight loss — compounded semaglutide and tirzepatide in injection, oral, and orally-dissolving-tablet forms, plus microdoses.
Publishes a price for every dose of every route — which makes it easy to brief, and expensive if you stay low.
On the record
The FDA issued a warning letter to Lovely Meds, Inc. dba Lovely Meds in September 2025. Try Ageless's own medical-oversight page identifies Lovely Meds, Inc. as the company that operates tryageless.com. The letter concerns lovelymeds.com, does not name tryageless.com, and FDA has not closed it out. Try Ageless keeps its place here and its link is unchanged — but you should know the letter exists before you start care. Read it in the FDA's warning letter database.
Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.